Ideen für Investitionen
Alle Bestände durchsuchen
Märkte
Ideen für Investitionen
›
Leverage Leaders
Screener bearbeiten
Erhalten Sie den New Stock Alert
Leverage Leaders
Ergebnisse
17
1 neu
🇭🇰 HK Markt
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
17 Unternehmen
1 neue Firma letzte 7d
Unternehmen
Letzter Preis
7D Rückkehr
1J Rückkehr
Marktkapitalisierung
Analysten Ziel
Bewertung
Wachstum
Div. Rendite
6990
Sichuan Kelun-Biotech Biopharmaceutical
HK$524.50
-1.6%
15.5%
HK$125.4b
HK$614.54
PE
711.2
E
44.0%
n/a
1801
Innovent Biologics
HK$107.60
6.3%
18.7%
HK$187.3b
HK$127.88
PE
130.4
E
34.1%
n/a
1177
Sino Biopharmaceutical
HK$5.64
4.5%
-27.2%
HK$100.4b
HK$8.45
PE
36.0
E
17.0%
2.5%
1530
3SBio
HK$17.15
3.9%
-38.0%
HK$42.7b
HK$31.36
PE
4.4
E
-41.0%
1.5%
3692
Hansoh Pharmaceutical Group
HK$36.82
9.3%
3.1%
HK$223.2b
HK$47.12
PE
28.7
E
7.3%
1.2%
2269
WuXi Biologics (Cayman)
HK$50.50
1.7%
62.7%
HK$207.2b
HK$54.76
PE
35.5
E
17.0%
n/a
867
China Medical System Holdings
HK$11.51
-3.0%
-11.3%
HK$28.0b
HK$17.77
PE
15.7
E
22.1%
3.0%
2268
WuXi XDC Cayman
HK$75.50
7.5%
41.0%
HK$95.6b
HK$90.89
PE
52.8
E
29.1%
n/a
2096
Simcere Pharmaceutical Group
HK$11.51
-5.7%
-13.3%
HK$29.6b
HK$17.62
PE
16.1
E
17.5%
1.8%
2315
Biocytogen Pharmaceuticals (Beijing)
HK$60.20
-1.5%
188.6%
HK$54.4b
HK$62.03
PE
79.4
E
41.0%
n/a
9606
Duality Biotherapeutics
HK$195.50
4.2%
-36.5%
HK$17.7b
HK$423.06
PS
8.2
E
89.8%
n/a
9995
Neu
RemeGen
HK$82.50
3.3%
-6.3%
HK$67.3b
HK$121.37
PE
6.8
E
-39.0%
n/a
1093
CSPC Pharmaceutical Group
HK$9.68
1.7%
2.5%
HK$110.7b
HK$12.44
PE
12.8
E
-7.0%
3.7%
1548
Genscript Biotech
HK$35.48
6.4%
109.0%
HK$77.6b
HK$29.17
PS
11.7
E
116.4%
0%
3696
InSilico Medicine Cayman TopCo
HK$47.02
6.4%
n/a
HK$27.1b
HK$80.62
PS
25.6
E
121.7%
n/a
3933
United Laboratories International Holdings
HK$8.69
-0.3%
-41.8%
HK$17.1b
HK$15.05
PE
7.0
E
7.3%
5.6%
512
Grand Pharmaceutical Group
HK$5.26
-4.0%
-42.0%
HK$18.4b
HK$11.90
PE
16.6
E
21.4%
3.2%
Page 1 of 1
Dashboard
Portfolios
Favoriten
Gemeinschaft
Entdecken
Suchen